MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MP-49-0005982
Super Formulations Private Limited - pharma in Ujjain, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹123.88 Cr
▲ 17% YoY
Net profit · FY 2024
₹13.19 Cr
Net margin 10.6%
EBITDA · FY 2024
₹19.87 Cr
EBITDA margin 16%
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹1.5 Cr
Issued & subscribed
Open charges
₹62.41 Cr
Secured borrowings
Company age
22 yrs
Est. 2004
Employees · EPFO
76
Provident fund records
About Super Formulations Private Limited
Data last updated:
Super Formulations Private Limited is a private limited company based in Ujjain, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 July 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP2004PTC016782. Its GSTIN is 23AAJCS0547G1ZJ (Madhya Pradesh). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.5 Cr. It is led by directors Jain Lavish (Managing Director) and Meghant Jain.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 16B 16D &15F Industrial Area Maxi Road, Ujjain, Madhya Pradesh, India – 456010.
As per the financials filed for FY 2024, the company reported a revenue of ₹123.88 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹13.19 Cr (net margin 10.6%) and EBITDA of ₹19.87 Cr (EBITDA margin 16%). Revenue has grown at a compounded annual rate (CAGR) of 42% over three years and 27% over five years.
The company has about 76 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Super Formulations. As per MCA filings, the company has open charges of ₹62.41 Cr on record. Court records list 44 cases involving the company, including 17 filed by the company and 27 filed against it; 21 cases are pending.
Super Formulations Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-49-0005982). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website superformulations.com.
Company details
CIN U24232MP2004PTC016782
Registration Number 016782
Incorporation Date 26 July 2004
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MP-49-0005982
Recognitions & Rankings of Super Formulations
Contact details
Super Formulations Private Limited's registered office is in Ujjain, Madhya Pradesh. Its website is superformulations.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address16B 16D &15F Industrial Area Maxi Road, Ujjain, Madhya Pradesh, India – 456010
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Super Formulations Private Limited, buy the company report.
Comprehensive company report
Super Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Super Formulations operates one associated brand: Super Formulations. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and markets pharmaceutical drugs for export and domestic markets worldwide. | superformulations.com |
Business activity
The main business activity of Super Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Super Formulations Private Limited, buy the company report.
Financials of Super Formulations Private Limited
FY 2024 filings availableSuper Formulations Private Limited reported revenue of ₹123.88 Cr (up 17% YoY) for FY 2024.
Revenue · FY 2024
₹123.88 Cr ▲ 17%
Net profit · FY 2024
₹13.19 Cr margin 10.6%
EBITDA · FY 2024
₹19.87 Cr margin 16%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 42%
5 years · compounded
▲ 27%
EBITDA CAGR growth
1 year
▲ 293%
3 years · compounded
▲ 104%
5 years · compounded
▲ 57%
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 17% growth in the latest year. EBITDA rose 293% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹123.88 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹19.87 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.19 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16% | ||||
| Net Profit Margin | 10.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Super Formulations Private Limited, buy the company report.
Board of directors of Super Formulations Private Limited
Super Formulations has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jain Lavish | Managing Director | 26 Jul 2004 | 22 Years 2 Months | Current |
| Meghant Jain | Director | 24 Dec 2021 | 4 Years 10 Months | Current |
Peer comparison
Super Formulations Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Koye Pharmaceuticals Private Limited | ₹129.09 Cr (FY 2025) | -4.0% | Mumbai, Maharashtra, India | |||
| Centurion Remedies Private Limited | ₹128.35 Cr (FY 2025) | -10.0% | Vadodara, Gujarat, India | |||
| Encore Healthcare Private Limited | ₹128.04 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India | |||
| Super Formulations Private Limitedthis company | ₹123.88 Cr (FY 2024) | ₹13.19 Cr | 10.6% | 17.0% | 76 | Ujjain, Madhya Pradesh, India |
| Rubicon Formulations Private Limited | ₹123.25 Cr (FY 2025) | 29.0% | Aurangabad, Maharashtra, India | |||
| Roopa Industries Limited | ₹122.98 Cr (FY 2025) | 72.0% | Kurnool, A.P, Andhra Pradesh, India | |||
| Nirchem Dyes & Chemicals Private Limited | ₹122.53 Cr (FY 2025) | 21.0% | Mumbai, Maharashtra, India | |||
| Realcade Lifescience Private Limited | ₹122.35 Cr (FY 2025) | 8.0% | Kadi, Gujarat, India |
To see the full peer comparison of Super Formulations Private Limited, buy the company report.
Auditor
Super Formulations Private Limited is audited by Amritlal H Jain & Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Amritlal H Jain & Co. | FY 2024 | 001052C |
Shareholding
The shareholding of Super Formulations Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Super Formulations Private Limited, buy the company report.
Charges & borrowings
Open charges
₹62.41 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 May 2025 | 101107194 | Others | ₹8 Cr | Open | |
| 04 Oct 2024 | 101022751 | Hdfc Bank Limited | ₹21.9 Lakh | Open | |
| 27 Jun 2022 | 100601235 | Hdfc Bank Limited | ₹1.5 Cr | Open | |
| 30 Nov 2021 | 100523071 | Hdfc Bank Limited | ₹33.5 Cr | Open | |
| 14 Sep 2021 | 100477402 | Sidbi | ₹2 Cr | Open |
To see the full charge records of Super Formulations Private Limited, buy the company report.
Total charge records: 8 View all charges
Legal cases
Super Formulations Private Limited has 44 court cases on record: 17 filed by Super Formulations, 27 filed against it. 21 cases are pending and 23 are disposed.
Total cases
44
Filed by the company
17
Filed against the company
27
Pending
21
Disposed
23
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 28 | 25 | 14 |
| High courts | 16 | 2 | 7 |
Cases on record (5 of 44)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TAMIL NADU | Writ petition | Filed by the company against Tamil Nadu Medical Services Corporation Ltd., and 1 other | Disposed |
| High Court, TAMIL NADU | Interim or miscellaneous application | Filed by the company against Tamil Nadu Medical Services Corporation Ltd., and 1 other | Disposed |
| District court, Chennai, Tamil Nadu | Criminal complaint | Filed against the company by an individual | Pending |
| High Court of Karnataka | Court case (CRL.P) | Filed by the company against State of Karnataka | Pending |
| District court, West Godavari, Andhra Pradesh | Criminal complaint | Filed against the company by State of A.P., Rep. by the Drugs Inspector, Tanuku | Pending |
To see the full case history of Super Formulations Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Super Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Super Formulations Private Limited has a workforce of 76 employees on its EPFO records as of Jan 10, 2026, across 1 active EPFO establishment.
Employee count
76
Active EPFO establishments
1
Employee growth
5.56%
GST
Super Formulations has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAJCS0547G1ZJ | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Super Formulations Private Limited, buy the company report.
Recent activity
Super Formulations Private Limited has 5 board changes on record since 2004: 2 appointments and 3 cessations. The latest: Meghant Jain was appointed as Director on 24 Dec 2021.
Charges
A charge with Others of Rs. 8.00 Cr registered on 22 May 2025 with Charge ID 101107194 was modified on 10 Dec 2025.
Charges
A charge with Others amounted to Rs. 8.00 Cr with Charge ID 101107194 was registered on 22 May 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 33.50 Cr registered on 30 Nov 2021 with Charge ID 100523071 was modified on 29 Dec 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.22 Cr with Charge ID 101022751 was registered on 04 Oct 2024.
AGM
Super Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Super Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.50 Cr with Charge ID 100601235 was registered on 27 Jun 2022.
Appointed
Meghant Jain was appointed as Director.
Ceased
Meghant Jain ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 33.50 Cr with Charge ID 100523071 was registered on 30 Nov 2021.
Charges
A charge with Sidbi amounted to Rs. 2.00 Cr with Charge ID 100477402 was registered on 14 Sep 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 8.50 Cr with Charge ID 100408532 was registered on 28 Oct 2020.
7 earlier events are in the company report.
Frequently asked questions
Super Formulations is an active private limited company based in Ujjain, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 July 2004 (22+ years old) and is registered under CIN U24232MP2004PTC016782.
Super Formulations has 2 current directors:
- Jain Lavish - Managing Director
- Meghant Jain - Director
The latest financial statements of Super Formulations on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Super Formulations is 23AAJCS0547G1ZJ, registered in Madhya Pradesh. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Super Formulations is U24232MP2004PTC016782. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Super Formulations has 44 court cases on record: 17 filed by the company and 27 filed against it. 21 are pending. Most are in the district courts.
Super Formulations was incorporated on 26 July 2004, making it 22+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Super Formulations by revenue are Koye Pharmaceuticals Private Limited, Centurion Remedies Private Limited, Encore Healthcare Private Limited, Rubicon Formulations Private Limited, Roopa Industries Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Meghant Jain was appointed as Director on 24 Dec 2021. Meghant Jain ceased to be Additional Director on 06 Dec 2021. Simmi Jain ceased to be Whole-Time Director on 07 Dec 2019. Super Formulations has 5 board changes on record in total.
Yes, Super Formulations is registered as a medium enterprise under Udyam registration (number: UDYAM-MP-49-0005982).
Super Formulations can be reached through the website superformulations.com. Its registered office is in Ujjain, Madhya Pradesh, India.